Navigation Links
Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
Date:4/18/2011

r. Ginsburg has authored the patent application for Cellceutix anticancer product Kevetrin™, which has been filed in the United States and other countries and has advised Cellceutix on patent and licensing matters during the past few years.

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism. More information is available on the Cellceutix web site at www.cellceutix.com.

This Press Release contains forward-looking statements that are based on our current expectations, beliefs and assumptions about the industry and markets in which Cellceutix Corporation operates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause Cellceutix's actual results to be materially different from any future results expressed or implied by these statements. Actual results may differ materially from what is expressed in these statements, and no assurance can be given that Cellceutix can successfully implement its core business strategy and improve future earnings.

The factors that may cause Cellceutix's actual results to differ from its forward-looking statements include: Cellceutix's current critical need for additional cash to sustain existing operations and meet ongoing existing obligations and capital requirements; Cellceutix's ability to implement its new product development and commercialization, enter into clinical trials, expand the intellectual property portfolio, and receive regulatory approvals in a timely and cost-effective manner. All forward-looking statements are also expressly qualified in their entirety by the cautionary statements inclu
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
2. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
5. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
6. Sonic Innovations Conducts National Training Events for Government Clinicians
7. Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
8. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. OXIS International Executives Interviewed on StockGoodies.com Radio
11. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
(Date:5/22/2015)... Today, Rhodes Pharmaceuticals L.P. announced that Aptensio ... for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will ... The announcement comes just one month ... Food and Drug Administration (FDA). ... capsule with an onset of effect of 1 ...
(Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
Breaking Medicine Technology:InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
... Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), ... M.D., chief medical officer, is scheduled to present at the ... Wednesday, May 25, 2011 at noon BST. Dr. Patou is ... A live audio webcast of Pacira,s presentation can be ...
... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ... specializing in the development, manufacturing, and marketing of branded ... annual general meeting of shareholders (the "Meeting") will be ... Beijing time. The meeting will be held in No.699-18, ...
Cached Medicine Technology:Pacira Pharmaceuticals, Inc. to Present at UBS Global Specialty Pharmaceuticals Conference 2Simcere Pharmaceutical Group Provides Notice of Annual General Meeting 2
(Date:5/22/2015)... 22, 2015 According to Berks and ... drug related death, totaling almost 2,500 confirmed drug deaths, as ... state officials, totals 2,489 deaths stemming from legal and illegal ... loses seven people every day to fatal overdoses or other ... out as one of the most rife with drug related ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all forms ... specialize in include decks, additions, kitchen remodeling, interior renovations, ... more. , The redesigned logo is a fresh ... It includes two geometrical lines that represent the engineering ... be used with many things associated with the company. ...
(Date:5/22/2015)... May 22, 2015 sweetFrog Enterprises, LLC. is ... Jacksonville, Texas. Jacksonville is now the 16th sweetFrog store located ... was listed as #22 on the Inc. 500 list of ... lived and worked in East Texas for 20 years and ... owner of the Jacksonville, and nearby Palestine, sweetFrog locations. “We ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Wimbledon Health ... vascular, electrocardiogram (EKG), echocardiogram and NCV testing , ... a highly respected All American National athlete, to the ... I find the high level of testing and information ... athlete and their athletic trainers, this way they can ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Ticket Down is ... New York Rangers NHL Eastern Conference Finals Tickets . ... unless specified otherwise in the ticket listing. , For ... are at the top of the Eastern Conference. One of ... its share of ups and downs over the years, but ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... (Nasdaq: BFRM ) announced that on Thursday, December ... quarter fiscal year 2008 financial,results. The Company will issue ... and will hold a conference call with investors at ... Chief Executive Officer Steve Basta and Chief Financial Officer,Derek ...
... Activists Awarded Three-Year $5.2,Million Grant, SAN FRANCISCO, ... of the International Treatment Preparedness Coalition,and Tides, announced ... for $5.2,million from the Bill & Melinda Gates ... in advocacy and educational,activities to increase access to ...
... Tenn., Dec. 5 National partners,from the 16th ... presented more than $1.7 million of the projected ... in the fight against,childhood cancer. Companies represented at ... Wild Wings, Casey,s General Store, Fox,& Hound, Hess ...
... Donates "Asthma & Allergy Friendly" Toys to Kids ... Dec. 5 The oldest and largest,allergy patient ... Allergy,Foundation of America (AAFA), made the holidays a ... to asthma, allergies or,other respiratory diseases by donating ...
... believe,in themselves can raise their aspirations, motivation and accomplishments,and ... others do them., So says Albert Bandura, a ... won the 2008 University of Louisville,Grawemeyer Award for Psychology. ... among 31 nominations from five countries., Bandura,s ideas ...
... MYL ),today announced that Matrix Laboratories Limited* ... Drug Administration (FDA) under the,President,s Emergency Plan for ... (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300 mg.,Matrix,s ... generic,tentative approval of Gilead Sciences Inc.,s Viread Tablets, ...
Cached Medicine News:Health News:BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 2Health News:HIV Collaborative Fund Receives Gates Foundation Grant for AIDS Treatment and Prevention Advocacy 3Health News:National Partners from St. Jude Halloween Promotion Presents More Than $1.7 Million to Help Fight Childhood Cancer 2Health News:Allergy Foundation Thinks Globally, Gifts Locally 2Health News:Self-Confidence Can Make Us Better, Says Grawemeyer Psychology Winner 2Health News:Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets 2
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO 2 Inc....
US Autoflow Single Chamber Stackable Water-Jacketed CO2/O2 Inc....
Listeria Enrichment Broth...
... the temperature at your lab bench. This compact ... 99 C*, with the "plus" being a cooling ... The thermoblocks for 0.2 ml**, 0.5 ml, 1.0 ... high degree of flexibility for a multitude of ...
Medicine Products: